Fausto Artico


Global R&D Tech Head and Director of Innovation and Data Science, Innovation Hub (R&D Tech) - GSK



Fausto has a double PhD (Information Technology and Computer Science), earning his second master's and PhD at the University of California, Irvine. Fausto also holds multiple certifications from MIT, Columbia University, London School of Economics and Political Science, Kellogg School of Management, University of Cambridge and soon also from University of California, Berkeley. He has worked in multi-disciplinary teams and has over 20 years of experience in academia and industry.
As a Physicist, Mathematician, Engineer, Computer Scientist, and High-Performance Computing (HPC) and Data Science expert, Fausto has worked on key projects at European and American government institutions and with key individuals, like Nobel Prize winner Michael J. Prather. After his time at NVIDIA corporation in Silicon Valley, Fausto worked at the IBM T J Watson Center in New York on Exascale Supercomputing Systems for the US government (e.g., Livermore and Oak Ridge Labs).



Fausto Artico

Sessions


  • Tuesday - March 28, 2023 - 09:25

    The need to understand and adopt new technologies

    • How to strategically adopt new technologies in the pharmaceutical supply chain
    • Challenges faced by the industry when adopting these new technologies
    • The importance of maintaining a secure and efficient pharmaceutical supply chain
    • New trends in pharmaceutical manufacturing including predictive analytics, digital twins, robotics and more
    • The potential risks associated with the adoption of new technologies in the pharmaceutical supply chain

      Presentation


  • Tuesday - March 28, 2023 - 14:55

    Executive Insights: How can pharmaceutical companies build a reliable and sustainable supply chain to increase efficiency?

    • How can pharma’s supply chains adapt to, and even thrive in the face of global disruption?
    • How can we combat the risks posed by counterfeit drugs and other threats in the pharmaceutical supply chain?
    • Is localization the key to strengthening supply chain resilience, or could other strategies bring better results?
    • What innovative strategies can governments and other policy-makers implement to ensure robust pharma supply chains both nationally and internationally in the years ahead?
    • What collaborative strategies will ensure a thriving supply chain?


 

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now